155 related articles for article (PubMed ID: 36564282)
21. Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy.
Schirrmacher V; van Gool S; Stuecker W
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361831
[TBL] [Abstract][Full Text] [Related]
22. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy.
Pitt JM; Marabelle A; Eggermont A; Soria JC; Kroemer G; Zitvogel L
Ann Oncol; 2016 Aug; 27(8):1482-92. PubMed ID: 27069014
[TBL] [Abstract][Full Text] [Related]
23. The role of macrophages in the tumor microenvironment and tumor metabolism.
Sadhukhan P; Seiwert TY
Semin Immunopathol; 2023 Mar; 45(2):187-201. PubMed ID: 37002376
[TBL] [Abstract][Full Text] [Related]
24. In Vivo Analysis of Tumor-Associated Macrophages in the Tumor Microenvironment.
Anfray C; Ummarino A; Calvo A; Allavena P; Torres Andón F
Methods Mol Biol; 2023; 2614():93-108. PubMed ID: 36587121
[TBL] [Abstract][Full Text] [Related]
25. A time for YAP1: Tumorigenesis, immunosuppression and targeted therapy.
Shibata M; Ham K; Hoque MO
Int J Cancer; 2018 Nov; 143(9):2133-2144. PubMed ID: 29696628
[TBL] [Abstract][Full Text] [Related]
26. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
Balta E; Wabnitz GH; Samstag Y
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260
[TBL] [Abstract][Full Text] [Related]
27. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
28. Combining precision oncology and immunotherapy by targeting the MALT1 protease.
Mempel TR; Krappmann D
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36270731
[TBL] [Abstract][Full Text] [Related]
29. Perturbed MafB/GATA1 axis after burn trauma bares the potential mechanism for immune suppression and anemia of critical illness.
Johnson NB; Posluszny JA; He LK; Szilagyi A; Gamelli RL; Shankar R; Muthumalaiappan K
J Leukoc Biol; 2016 Oct; 100(4):725-736. PubMed ID: 26992433
[TBL] [Abstract][Full Text] [Related]
30. Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors.
Johnson A; Townsend M; O'Neill K
Cells; 2022 Nov; 11(22):. PubMed ID: 36429054
[TBL] [Abstract][Full Text] [Related]
31. Roles for macrophage-polarizing interleukins in cancer immunity and immunotherapy.
Mortezaee K; Majidpoor J
Cell Oncol (Dordr); 2022 Jun; 45(3):333-353. PubMed ID: 35587857
[TBL] [Abstract][Full Text] [Related]
32. Engineering Nanoparticles for Targeted Remodeling of the Tumor Microenvironment to Improve Cancer Immunotherapy.
Gao S; Yang D; Fang Y; Lin X; Jin X; Wang Q; Wang X; Ke L; Shi K
Theranostics; 2019; 9(1):126-151. PubMed ID: 30662558
[TBL] [Abstract][Full Text] [Related]
33. Dual role of endothelial
Kabir AU; Subramanian M; Lee DH; Wang X; Krchma K; Wu J; Naismith T; Halabi CM; Kim JY; Pulous FE; Petrich BG; Kim S; Park HC; Hanson PI; Pan H; Wickline SA; Fremont DH; Park C; Choi K
Sci Transl Med; 2021 Mar; 13(583):. PubMed ID: 33658356
[TBL] [Abstract][Full Text] [Related]
34. Immunometabolism at the Nexus of Cancer Therapeutic Efficacy and Resistance.
Traba J; Sack MN; Waldmann TA; Anton OM
Front Immunol; 2021; 12():657293. PubMed ID: 34079545
[TBL] [Abstract][Full Text] [Related]
35. Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein-Barr Virus-Associated Malignancies.
Zheng X; Huang Y; Li K; Luo R; Cai M; Yun J
Viruses; 2022 May; 14(5):. PubMed ID: 35632758
[TBL] [Abstract][Full Text] [Related]
36. [Interleukin-34: a key molecule in the tumor microenvironment].
Kajihara N; Seino KI
Rinsho Ketsueki; 2021; 62(8):1302-1307. PubMed ID: 34497220
[TBL] [Abstract][Full Text] [Related]
37. V-Maf Musculoaponeurotic Fibrosarcoma Oncogene Homolog A Synthetic Modified mRNA Drives Reprogramming of Human Pancreatic Duct-Derived Cells Into Insulin-Secreting Cells.
Corritore E; Lee YS; Pasquale V; Liberati D; Hsu MJ; Lombard CA; Van Der Smissen P; Vetere A; Bonner-Weir S; Piemonti L; Sokal E; Lysy PA
Stem Cells Transl Med; 2016 Nov; 5(11):1525-1537. PubMed ID: 27405779
[TBL] [Abstract][Full Text] [Related]
38. Multifunctional Redox-Responsive Nanoplatform with Dual Activation of Macrophages and T Cells for Antitumor Immunotherapy.
Zhang W; Liu X; Cao S; Zhang Q; Chen X; Luo W; Tan J; Xu X; Tian J; Saw PE; Luo B
ACS Nano; 2023 Aug; 17(15):14424-14441. PubMed ID: 37498878
[TBL] [Abstract][Full Text] [Related]
39. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
[TBL] [Abstract][Full Text] [Related]
40. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
